Introduction

The novel coronavirus disease (COVID-19) was declared to be a global pandemic on March 12, 2020, by the World Health Organization [1]. In an effort to try to mitigate the transmission of this deadly disease, several recommendations were enacted by the CDC, among them were encouraging the populace to limit any outdoor activities, including elective in-person clinic visits [2]. These recommendations had a significant impact with regard to ambulatory care. For decades, many restrictions had prevented expansion of telehealth services, however, on March 17, 2020, the Centers for Medicare and Medicaid Services (CMS) issued an 1135 waiver which allowed for the expansion of telehealth coverage for all Medicare patients. This allowed physicians to expand their use of telemedicine by eliminating barriers such as lack of reimbursement, licensing restrictions, and HIPAA compliance [3]. The pandemic along with removal of barriers to telehealth expansion caused a shift from in person ambulatory care to remote visits as a way to deliver medical care without risking transmission [2].

Telehealth offered an easy way for physicians to provide care and maintain connections with their patients, all while practicing social distancing [3]. This shift to telemedicine was not just limited to primary care. Several specialties adopted telehealth as a way to deliver care. A study conducted at the University of California Comprehensive Cancer Center showed that a shift to telehealth visits allowed patients to maintain access to complex oncologic care without any disparity based on race/ethnicity, primary language, or insurance, during the pandemic [4]. The American College of Obstetrics & Gynecology had also released guidelines on the use of telehealth during the pandemic. This allowed for several obstetrics & gynecology practices to shift their ambulatory care to telehealth comfortably [5]. Another study showed great patient satisfaction with telehealth for both gastroenterology providers and patients when the use of telehealth increased dramatically during the COVID-19 pandemic [6].

The field of cardiology presented a unique opportunity for telehealth, as cardiovascular disease (CVD) commonly occurs as a result of a combination of risk factors that must be continually addressed. The 2010 Global Burden of Disease study demonstrated that the burden of ischemic heart disease has risen significantly since 1990 with a significant proportion of the burden of CVD being preventable [7]. A 2010 study showed that in the US alone between 36% and 63% of myocardial infarctions could be prevented through risk factor reduction [8]. Continually treating these modifiable risk factors in outpatient visits is integral to preventing further CVD. Telehealth provided the perfect opportunity to deliver this care during the pandemic.

This paper seeks to investigate the advantages and potential barriers in regards to the use of telehealth in the field of cardiology. It will further investigate advantages, barriers and issues specific to certain diagnoses, and how telehealth has an impact on the practice of cardiologists in the outpatient setting.

Cardiology and COVID-19

As more and more studies on COVID-19 were published and the disease itself was studied, it became clear that common comorbidities such as hypertension, diabetes, and established cardiovascular disease conferred the highest risk of developing severe forms of COVID-19. In fact, the CDC lists the presence of heart failure, coronary artery disease, and hypertension as conditions that may put patients at a higher risk to become severely ill from COVID-19 [9, 10]. Furthermore, the presence of underlying CVD increases both the severity of the primary respiratory disease and the risk of developing subsequent complications [10, 11]. A recent study found that CVD and associated risk factors were associated with fatal outcomes with COVID-19 across all age groups, thus demonstrating the importance of paying special attention to addressing cardiovascular comorbidities in the young and the elderly in outpatient visits [11]. However, with stay-at-home orders being given worldwide to reduce the transmission of COVID-19, outpatient visits to follow-up on these risk factors have also been reduced. The medical community responded to this change with the fast rise and expansion of telemedicine with the field of cardiology being no exception. With the adoption of telemedicine in cardiology, a set of new challenges and opportunities arose that very well may change the future of outpatient cardiology visits.

Advantages to Telehealth in the Field of Cardiology

With the transition to telemedicine, several advantages were noted in remote cardiology clinic visits. The most noted advantage was that patients saw a reduction in travel time and wait time. Patients also ranked reduced travel time as a significant advantage in addition to decreased travel costs [13••]. Patients also noted that with telehealth visits, there was a decreased wait time. Telehealth allowed for patients to be notified by telephone, thus avoiding the wait that sometimes accompanies in-person visits. Surveys of patients also show an increased comfort level with telemedicine visits and the ability to continue to work at their jobs as prime advantages [13••, 14]. Furthermore, video visits allow patients to show physicians their prescription bottles allowing for medication reconciliation to be done. Overall, patient satisfaction remained stable when comparing in-person visits and telehealth visits during the pandemic [13••, 14]. Additionally, there were studies showing that remote visits equally replaced the decrease in in-person patient visits during the COVID-era period, demonstrating patient comfort with the transition [15]. Cardiologists were also surveyed, and despite many having no prior experience, they were satisfied with the transition overall [16•]. With CMS having extended reimbursement for virtual visits during the COVID-era, time will tell if these changes are here to stay. However, with what appears to be the successful transition to telehealth in cardiology clinics, it would behoove CMS to continue to extend this and further grow this advancement.

Potential Barriers to Telehealth in Cardiology

The great potential of telehealth has always been tempered by concerns of lack of access. Patients who are older and who live in rural areas with lack of consistent internet or have less education may be at higher risk of not receiving telehealth [13••, 17]. Additionally, communities that are underserved with healthcare services may also be those with limited access to reliable internet service or lack understanding on how to deploy telehealth technology [17]. Studies that focused on cardiology outpatient telehealth visits revealed a sharp contrast from this theory. These studies revealed that during the pandemic, internet and technology access were not significant barriers to the use of telehealth [13••]. A study conducted in Kentucky found that among their respondents who declined to use telehealth, only 6.2% cited access to technology as a reason [6]. Furthermore, more than 70% of respondents reported unfamiliarity with technology as not being a factor in declining telehealth or as a disadvantage, among those who participated. These findings suggest that even during a period with rapid change to telehealth, internet access or the use of technology did not act as significant barriers.

While access to technology seemingly did not act as a barrier, age appeared to be one such factor. Older patients had difficulties with telemedicine technology including using video visits less frequently [16•]. This is consistent with prior literature which has shown lower rates of telemedicine use among patients 75–84 years old [18, 19]. This is rather concerning with respect to cardiology visits, as elderly patients tend to have multiple comorbidities and risk factors that require close monitoring. A cross-sectional study by Yuan et al. showed that older patients used video visits less frequently for cardiology remote visits. However, recent data has shown that a growing number of older adults have smartphones and that with some guidance on using new technology by clinic support staff or the integration of telehealth into a platform already familiar with patients, such as patient portals, older adults may be able to combat this disparity. As telehealth grows, different approaches to combat the barriers that the elderly face will be necessary [16•].

In addition to age, the pandemic revealed inequities in care which may be manifested with the use of telemedicine. Populations that were non-English speaking, poorer, lacked insurance, female, and as previously mentioned, older, were associated with a lower telemedicine use. The inability to speak English was found to be independently associated with a > 50% lower telemedicine use [12]. While virtual interpreter services do exist, the adoption of such services into telehealth must occur to address this inequity. With the shift to telemedicine, studies have shown a modest decline in outpatient visits in lower income populations with no consensus as to a possible etiology. Despite the seeming advantages of telemedicine, healthcare disparities are not eliminated with its use. As telemedicine continues to grow, attention to disparities in the aforementioned populations, as well as barriers which may not have revealed themselves given the pioneering and somewhat experimental nature of telehealth expansion, needs to remain a focus.

A perceived barrier from the physician side of telehealth included the lack of a comprehensive physical exam [16•]. This issue is particularly important in the field of cardiology as the physical exam can influence the subsequent laboratory or imaging orders physicians may make. Findings such as an irregular rhythm or volume status, which can be easily checked with a comprehensive physical exam, can be difficult, if not impossible, to do in a telehealth visit. Basic components of the physical examination can be performed over video-assisted telehealth visits such as general appearance, alertness and orientation, and checking for signs of peripheral edema. Recent developments in video technology have also showed that magnification into the patient’s neck veins may accurately correlate with invasive measured right atrial pressure [15, 16•]. However, these benefits may all be null, as elderly populations struggle to use video visits properly. Furthermore, there is a decrease in patient satisfaction between in-person and telehealth visits regarding the clinical exam due to lack of video [16•]. Thus, in order for the use of telehealth to expand within the field of cardiology, mechanisms must be put in place that allow physicians and healthcare administrators to educate their patients on the usage of this technology to better facilitate video visits to allow for a basic physical exam.

Specific Cardiology Diagnoses in the Outpatient Setting

Congestive Heart Failure

Congestive heart failure (CHF) represents one aspect of cardiology that requires routine outpatient care, thus making it the perfect platform to see telehealth in action. Telemedicine visits allow physicians to perform medication reconciliation, adjust dosages of guideline-directed medical therapy, counsel patients regarding diet and medication compliance, and discuss symptoms that may be problematic such as orthopnea, paroxysmal nocturnal dyspnea, and edema. Additionally, telehealth has allowed for patient caregivers or family members to be involved in patient appointments at a time when visiting restrictions would make this interaction or involvement impossible [20]. While compensated CHF patients can be easily managed via telehealth, assessing patients with acute symptoms over telehealth becomes challenging. Like in-person visits, telehealth visits should be classified as urgent or routine, and the physician must triage to determine if certain telehealth patients must be seen in-person. Urgent classification may encompass visits regarding worsening CHF symptoms such as acute dyspnea, excessive fatigue particularly with exertion, or development of edema or rapid weight gain, among others. Dyspnea, in particular, must be managed with special care in cardiology telehealth visits given the importance of differentiating an acute CHF exacerbation from COVID-19 infection. While the challenges of a lack of a complete physical exam and education of the elderly remain, especially in heart failure patients, solutions such as remote monitoring and elderly education rise as viable solutions. In fact, studies that included either automated monitoring of signs and symptoms or automated physiologic monitoring showed a 27–40% reduction in CHF decompensation admissions and a reduction of all-cause mortality [21, 22]. A recent retrospective study comparing home telemedicine care with outpatient care showed that home telemedicine was associated with improved survival. The trend of reduced mortality was seen throughout follow-ups, up to 60 months from the initial encounter. The study theorized that the reduced mortality in home telemedicine patients may reflect the improved patient CHF knowledge and self-care behaviors that are reinforced during these visits [23]. Given the success of managing compensated heart failure patients via telehealth and the high patient satisfaction seen in studies, many CHF programs across the country have already converted previously in-person visits into telehealth visits, demonstrating a possible transition to telehealth medicine for chronic CHF patients in the future [20].

Atrial Fibrillation

Atrial fibrillation may be especially well suited for telehealth medicine as these visits lend themselves to incorporating remote patient monitoring. Studies before the pandemic have shown the value in digital electrocardiograms in detecting abnormal rhythms [24, 25]. Holter monitors and other rhythm monitors can be mailed to patients in the event a physician is concerned about a patient’s heart rate. Furthermore, with the field of wearable smart watches increasing, more and more devices can recognize arrhythmias. Studies are currently being conducted to find if there is a benefit of wearable devices use in healthcare and its impact [26]. During these telehealth visits, all cardiac imaging can be reviewed with patients, and physicians can also assess for symptoms associated with uncontrolled atrial fibrillation. If there are any changes required in dosing of rate control medications, remote patient monitoring will play a valuable role [24, 25]. While there are findings associated with atrial fibrillation, such as exertional syncope or worsening palpitations, which may necessitate that a patient should be seen in-person, the feasibility of chronic management via telehealth remains a possibility for these patients in the future.

Ischemic Heart Disease

In addition to common cardiovascular conditions such as atrial fibrillation and CHF, telehealth has significant potential in treating ischemic heart disease. Patients discharged after an acute coronary syndrome should be followed up promptly to check on symptoms, treatment adherence, and optimization [25]. All of these can be addressed during telehealth visits. Telehealth visits would also allow cardiologists to check on status of worsening ischemic heart disease symptoms such as worsening angina or new onset heart failure symptoms. While reviewing blood pressure and heart rate logs with the patient, cardiologists would be able to successfully further optimize treatments [25, 27]. Telemedicine visits would also allow for the routine counseling cardiologists provide regarding lifestyle modifications to be delivered. While further studies need to be determined as to the effectiveness of telehealth interventions in reducing overall CVD risk, the Spanish Society of Cardiology recently came out with a guide on how to treat ischemic heart disease over telehealth visits, thus providing an example of the faith in delivering adequate care via telehealth [25, 27].

The Impact of Telehealth on Cardiologists

The transition to telemedicine in cardiology visits has also impacted physician practices. Prior literature had concerns about telemedicine visits in regard to the frequency of laboratory testing and imaging orders or medication prescriptions, as experts argued that the lack of physical exam during remote visits would lead to the overuse of unnecessary testing and the over-prescribing of medications [13••]. A study by Yuan et al. showed a different result however, as there was a stepwise reduction in the ordering frequency of both diagnostic tests and prescription medications when comparing pre-COVID and COVID-era telemedicine visits to in-person visits [13••]. While the study offers no direct reason for why this occurred, the authors suggested reduced access, as many of the tests that would be ordered, such as labs, would often be performed in a facility which patients did not wish to visit particularly in light of the COVID-19 pandemic. Other studies have noted similar results with telehealth visits being associated with fewer new medication prescriptions, electrocardiograms, echocardiograms, and stress tests ordered [28]. There may also be a tie to the previously discussed issues with physical examination as the lack of physical exam may lead to physicians not feeling comfortable ordering tests or prescribing medications if not cued by findings on physical exam. Support for this theory gained more merit from a study which showed that telephone visits led to less tests or medications ordered when compared with video visits. Despite the possible reasons for the lower frequency of testing during telehealth visits, further research is required to determine if this finding is due to a lack of indication, patient discomfort with performing the tests during a pandemic or cardiologists feeling relatively less comfortable in a telehealth setting [28].

Conclusion: Future of COVID, Cardiology, and Telemedicine

With the rollout of COVID-19 vaccinations and reduction of restrictions from the CDC, the pandemic may be in its final stages. The pandemic caused by COVID-19 however leaves behind a lasting impact on the healthcare system [15, 29]. With the slow return of society to normal, clinicians must decide whether there is a future for telehealth visits, and they will use the lessons learned from the pandemic to decide. Studies have shown very high satisfaction among patients and practitioners with virtual visits during the pandemic [13••, 16•]. While there are barriers and inequities in care still present, the field of telemedicine is fast growing. Particular to cardiology, telemedicine visits to address chronic medical illnesses such as CHF and atrial fibrillation may increase in the future as both cardiologists and patients become more comfortable with this mode of healthcare. Concerns regarding physical exam and lack of objective data during these visits are slowly being addressed with remote monitoring technologies such as biosensing wearables and watches and Holter monitors. Further studies will need to be done to determine if telehealth visits can lead to greater adherence, decrease no-show rates, improve access to healthcare, and improve transition of care [29]. However, now that the gates of telemedicine have been opened by the pandemic, it will be interesting to see how it continues to grow in the field of cardiology.